颈动脉血运重建后中期再狭窄预测因素的多中心数据库分析
CAS后再狭窄更易出现症状且需再次血运重建,支架后球囊扩张及CEA补片和完成影像可降低再狭窄风险。
要点
- CAS后再狭窄更易有症状(OR 2.2)并需再次血运重建(HR 1.75)。
- 支架后球囊扩张、CEA补片和完成影像与再狭窄风险降低相关。
核心结论
- CEA与CAS两年再狭窄率无显著差异。
- CAS后再狭窄更易表现为症状并需再次血运重建。
- 支架后球囊扩张及CEA补片和完成影像与再狭窄风险降低相关。
研究设计与样本
- 基于血管质量倡议(VQI)数据库2003-2016年数据回顾性分析。
- 共纳入35720例颈动脉血运重建手术(CEA 31329例,CAS 4391例)。
- 排除无随访(33%)及同侧既往CEA或CAS患者。
- 再狭窄定义为≥70%直径狭窄、靶动脉闭塞、收缩期峰值流速≥300 cm/s或再次血运重建。
- 采用Kaplan-Meier生存分析和自举法Cox回归模型(逐步前向和后向选择)。
临床怎么用
- 对于CAS患者,支架后球囊扩张可能与降低再狭窄风险相关。
- 对于CEA患者,采用补片和完成影像可能降低再狭窄风险。
- CAS后再狭窄患者应警惕症状出现和再次血运重建需求。
局限性
- 需进一步研究评估长期结局并平衡某些实践(如支架后球囊扩张)的风险与获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Restenosis after carotid revascularization is clinically challenging. Several studies have looked into the management of recurrent restenosis; however, studies looking into factors associated with restenosis are limited. This study evaluated the predictors of restenosis after carotid artery stenting (CAS) and carotid endarterectomy (CEA) using a large national database. METHODS: Patients undergoing CEA or CAS in the Vascular Quality Initiative data set (2003-2016) were analyzed. Patients with no follow-up (33%) and those who had prior ipsilateral CEA or CAS were excluded. Significant restenosis was defined as ≥70% diameter-reducing stenosis, target artery occlusion or peak systolic velocity ≥300 cm/s, or repeated revascularization. Kaplan-Meier survival analysis and bootstrapped Cox regression models with stepwise forward and backward selection were used. RESULTS: A total of 35,720 procedures were included (CEA, 31,329; CAS, 4391). No significant difference in restenosis rates was seen between CEA and CAS at 2 years (7.7% vs 9.4% [P = .09]; hazard ratio [HR], 0.99; 95% confidence interval [CI], 0.79-1.25; P = .97). However, after adjustment for age, sex, and symptomatic status at the time of the index operation, CAS patients who had postoperative restenosis were more likely to have a symptomatic presentation (odds ratio, 2.2; 95% CI, 1.2-4.0; P = .01) and to undergo repeated revascularization at 2 years (HR, 1.75; 95% CI, 1.3-2.4; P < .001) compared with patients who had restenosis after CEA. Predictors of restenosis after CAS included a common carotid artery lesion (HR, 1.65; 95% CI,1.06-2.57; P = .03), whereas age (HR, 0.91; 95% CI, 0.84-0.99; P = .03) and dilation after stent placement (HR, 0.53; 95% CI, 0.39-0.72; P < .001) were associated with decreased restenosis at 2 years. Predictors of restenosis after CEA included female sex (HR, 1.55; 95% CI, 1.38-1.74; P < .001), prior neck irradiation (HR, 2.35; 95% CI, 1.66-3.30; P < .001), and prior bypass surgery (HR, 1.29; 95% CI, 1.01-1.65; P = .04). On the other hand, factors associated with decreased restenosis after CEA included age (HR, 0.95; 95% CI, 0.92-0.98; P < .001), black race (HR, 0.57; 95% CI, 0.37-0.89; P = .01), patching (HR, 0.61; 95% CI, 0.47-0.79; P < .001), and completion imaging (HR, 0.70; 95% CI, 0.52-0.95; P = .02). CONCLUSIONS: Our results show no significant difference in restenosis rates at 2 years between CEA and CAS. Restenosis after CAS is more likely to be manifested with symptoms and to undergo repeated revascularization compared with that after CEA. Poststent ballooning after CAS and completion imaging and patching after CEA are associated with decreased hazard of restenosis; however, further research is needed to assess longer term outcomes and to balance the risks vs benefits of certain practices, such as poststent ballooning.
引用
- Dakour-Aridi H, Mathlouthi A, Locham S, et al. Predictors of midterm high-grade restenosis after carotid revascularization in a multicenter national database. J Vasc Surg. 2020. PMID: 32085958. doi:10.1016/j.jvs.2019.07.100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。